TGF-β1 was found to promote the development of liver fibrosis in mice by activating the Smad, p38 MAPK and PI3K/AKT signaling pathways, causing an increase in aerobic glycolysis in HSC and inducing GLUT1 expression in HSC. This evidence concerns the gene TGFB1 and Hepatic fibrosis.